Ehsan Allah Kalteh - Infectious Disease Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Aiuob Sofizadeh - Infectious Disease Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Mohammad Fararooei - Department of Epidemiology, School of Health, HIV/AIDS Research Center, Research Institute for Health, Shiraz University of Medical Sciences, Shiraz, Iran
Mousa Chelichi Ghojogh - Department of Epidemiology, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
Somayeh Aljalili - Health Center of Kavar, Shiraz University of Medical Sciences, Shiraz, Iran

In late ۲۰۱۹, a novel coronavirus, now designated severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲) was identified as the cause of an outbreak of acute respiratory illness in Wuhan, a city in China. Mortality rate, case fatality rate, and Years of Potential Life Lost can be measured by determining death cases. Much of our information on mortality rates of diseases can be obtained through a regular implementation of care plans that are often developed to screen infectious diseases. In the YLL component, the higher the individuals die at an earlier age, the longer their life is lost. For COVID-۱۹, this component refers to the simple subtraction of age at death due to COVID-۱۹ from the standardized life expectancy for the same age in the same sex. A potential application of health summary indices is to consider the non-fatal consequences of diseases to ensure that they are taken into account in health policy making. Given that COVID-۱۹ has a non-fatal effect on a large number of patients, the estimation of disease burden using the DALYs may be an appropriate index for achieving this goal.

Coronavirus; Mortality rate; Case fatality rate; Covid-۱۹; SARS; MERS